keyword
https://read.qxmd.com/read/38093823/a-case-report-of-myocardial-infarction-in-a-young-transgender-man-with-testosterone-therapy-raising-awareness-on-healthcare-issues-in-the-transgender-community-and-a-call-for-further-research
#21
Paul J Connelly, Joanna Osmanska, Matthew M Y Lee, Christian Delles, Margaret B McEntegart, John Byrne
BACKGROUND: People who are transgender may utilize masculinizing or feminizing gender-affirming hormonal therapy. Testosterone and oestrogen receptors are expressed throughout the cardiovascular system, yet the effects of these therapies on cardiovascular risk and outcomes are largely unknown. We report the case of a young transgender man with no discernible cardiovascular risk factors presenting with an acute coronary syndrome. CASE SUMMARY: A 31-year-old transgender man utilizing intramuscular testosterone masculinizing gender-affirming hormonal therapy presented with central chest pain radiating to the left arm...
December 2023: European Heart Journal. Case Reports
https://read.qxmd.com/read/38078460/the-association-between-ace-inhibitors-and-psoriasis-based-on-the-drug-targeted-mendelian-randomization-and-real-world-pharmacovigilance-analyses
#22
JOURNAL ARTICLE
Qiubai Jin, Feihong Ren, Ping Song
BACKGROUND: Although a growing number of observational studies suggest that angiotensin-converting enzyme inhibitors (ACEIs) intake may be a risk factor for psoriasis, evidence is still insufficient to draw definitive conclusions. RESEARCH DESIGN AND METHODS: Drug-targeted Mendelian randomization (DTMR) was used to analyze the causality between genetic proxied ACEIs and psoriasis. Furthermore, we performed a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database to identify more suspicious subclasses of ACEIs...
December 11, 2023: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38069366/cardioprotective-and-antifibrotic-effects-of-low-dose-renin-angiotensin-aldosterone-system-inhibitors-in-type-1-diabetic-rat-model
#23
JOURNAL ARTICLE
Dora B Balogh, Agnes Molnar, Arianna Degi, Akos Toth, Lilla Lenart, Adar Saeed, Adrienn Barczi, Attila J Szabo, Laszlo J Wagner, Gyorgy Reusz, Andrea Fekete
Diabetic cardiovascular complications are associated with up to 50% mortality, and current therapies are not effective enough. Renin-angiotensin-aldosterone system inhibitors (RAASis) are the standard of care for diabetic patients with hypertension and albuminuria. Based on our previous studies reporting the renoprotective effects of low-dose RAASis, here, we hypothesized that low-dose RAASi treatment has cardioprotective and antifibrotic benefits in type 1 diabetes mellitus (T1DM). After five weeks of T1DM, adult male Wistar rats received low doses of ramipril, losartan, or eplerenone for two weeks...
December 1, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/38032920/interactive-effect-of-oral-anti-hyperglycaemic-or-anti-hypertensive-drugs-on-the-inhibitory-and-bactericidal-activity-of-first-line-anti-tb-drugs-against-m-tuberculosis
#24
JOURNAL ARTICLE
Priyanka Trivedi, Vinita Chaturvedi
Co-existence of life style disorders, like, Diabetes or Hypertension, increases risk of, treatment failure, deaths and developing drug-resistant TB. Concomitant administration of drugs to treat dual/multi-morbidities may alter their effectiveness, in additive/synergistic or adverse/antagonistic manner. We evaluated interactive effect of 7 anti-hyperglycaemic (HG) and 6 anti-hypertensive (HT) drugs on the inhibitory (MICs) and bactericidal (% killing of intracellular bacilli) activities of anti-TB drugs, Isoniazid (INH), Rifampicin (RFM), Ethambutol (EMB) and Streptomycin (STR) against M...
2023: PloS One
https://read.qxmd.com/read/37992807/testicular-ace-regulates-sperm-metabolism-and-fertilization-through-the-transcription-factor-ppar%C3%AE
#25
JOURNAL ARTICLE
Tomohiro Shibata, Shabir A Bhat, DuoYao Cao, Suguru Saito, Ellen A Bernstein, Erika Nishi, Juliet D Medenilla, Erica T Wang, Jessica L Chan, Margareta D Pisarska, Warren G Tourtellotte, Jorge F Giani, Kenneth E Bernstein, Zakir Khan
Testis angiotensin-converting enzyme (tACE) plays a critical role in male fertility, but the mechanism is unknown. Sperm motility and fertilization depend on energy metabolism. By using ACE C-domain knockout (CKO) mice which lack tACE activity, we found that ATP in CKO sperm was 9.4-fold lower than WT sperm. Similarly, an ACE inhibitor (ACEi) reduced ATP production in mouse sperm by 72%. Metabolic profiling showed that tACE inactivation severely affects oxidative metabolism with decreases in several Krebs cycle intermediates including citric acid, cis-aconitic acid, NAD, α-ketoglutaric acid, succinate, and L-malic acid...
November 20, 2023: Journal of Biological Chemistry
https://read.qxmd.com/read/37961402/multi-spectral-fluorescent-reporter-influenza-a-viruses-allow-for-in-vivo-studies-of-innate-immune-function-in-zebrafish
#26
Brandy-Lee Soos, Alec Ballinger, Mykayla Weinstein, Haley Foreman, Julianna Grampone, Samuel Weafer, Connor Aylesworth, Benjamin L King
Influenza virus infection can cause severe respiratory disease and is estimated to cause millions of illnesses annually. Studies of the contribution of the innate immune response to influenza A virus (IAV) to viral pathogenesis may yield new antiviral strategies. Zebrafish larvae are useful models to study the innate immune response to pathogens, including IAV, in vivo . Here, we demonstrate how Color-flu, four fluorescent IAV strains originally developed for mice, can be used to study host-virus interactions by simultaneously monitoring virus particles, neutrophils, and macrophages in vivo ...
November 2, 2023: bioRxiv
https://read.qxmd.com/read/37942034/takotsubo-cardiomyopathy-following-a-virtual-work-meeting-during-covid-19-pandemic-a-case-report
#27
Ernan Zhu, Katharina Scherschel, Manfred Schedlowski, Christian Meyer
BACKGROUND: Coronavirus disease 2019 (COVID-19) has a great impact on both, physical and psychological wellbeing. The COVID-19 pandemic promoted increasing digitalization of the work environment and social isolation. This psychosocial stress in turn can induce physical distress with clinical manifestation. So can the changed work and social environment in the COVID-19 pandemic trigger acute cardiovascular disease? CASE DESCRIPTION: Here, we present a case of a 56-year-old postmenopausal woman suffering from Takotsubo cardiomyopathy (TTC) evoked by emotional stress during a virtual work meeting...
2023: AME Case Reports
https://read.qxmd.com/read/37933184/sacubitril-valsartan-compared-to-ramipril-in-high-risk-post-myocardial-infarction-patients-stratified-according-to-use-of-mineralocorticoid-receptor-antagonists-insight-from-the-paradise-mi-trial
#28
JOURNAL ARTICLE
Morten Schou, Brian Claggett, Zi Michael Miao, Alberto Fernandez, Gerasimos Filippatos, Christopher Granger, Karola Jering, Aldo P Maggioni, Finnian McCausland, Julio Nuñez Villota, Jean-Lucien Rouleau, Freny Vaghaiwalla Mody, Peter van der Meer, Dragos Vinereanu, Martina McGrath, Yinong Zhou, Douglas L Mann, Scott D Solomon, Philippe Gabriel Steg, Eugene Braunwald, John J V McMurray, Marc A Pfeffer, Lars Køber
AIM: It is unknown whether safety and clinical endpoints by use of sacubitril/valsartan (an angiotensin receptor-neprilysin inhibitor [ARNI]) are affected by mineralocorticoid receptor antagonists (MRA) in high-risk myocardial infarction (MI) patients. The aim of this study was to examine whether MRA modifies safety and clinical endpoints by use of sacubitril/valsartan in patients with a MI and left ventricular systolic dysfunction (LVSD) and/or pulmonary congestion. METHODS AND RESULTS: Patients (n = 5661) included in the PARADISE MI trial (Prospective ARNI vs...
November 6, 2023: European Journal of Heart Failure
https://read.qxmd.com/read/37789702/development-of-diabetic-macular-oedema-shows-associations-with-systemic-medication-an-epidemiological-study
#29
JOURNAL ARTICLE
Sirpa Loukovaara, Ani Korhonen, Leo Niskanen, Jari Haukka
PURPOSE: To identify associations between systemic drugs and the incidence of diabetic macular oedema (DME). Of interest was to find beneficial and/or deleterious associations of used drugs. METHODS: A historic cohort design based on administrative data. Study population consisted of 150 353 individuals with diabetes. Endpoint event was the development of DME (ICD-10 H36.01), censoring events were death or study end December 2017. The follow-up started between 1997 and 2010...
October 3, 2023: Acta Ophthalmologica
https://read.qxmd.com/read/37741921/repurposing-fexofenadine-as-a-promising-candidate-for-diabetic-kidney-disease-randomized-clinical-trial
#30
JOURNAL ARTICLE
Basma Mahrous El-Fatatry, Sahar Mohamed El-Haggar, Osama Mohamed Ibrahim, Khaled Hamed Shalaby
PURPOSE: Diabetic kidney disease (DKD) is a devastating complication of diabetes mellitus. Inflammation and histamine are potentially involved in the disease progression. This study aimed to evaluate the role of fexofenadine in patients with DKD. METHODS: From January 2020 to February 2022, out of 123 patients screened for eligibility, 61 patients completed the study. Patients were randomized into two groups, the fexofenadine group (n = 30): received ramipril plus fexofenadine, and the control group (n = 31): received ramipril only for six months...
September 23, 2023: International Urology and Nephrology
https://read.qxmd.com/read/37734804/a-cardiovascular-polypill-for-secondary-stroke-prevention-in-a-tertiary-centre-in-ghana-smaart-a-phase-2-randomised-clinical-trial
#31
RANDOMIZED CONTROLLED TRIAL
Fred Stephen Sarfo, Jenifer Voeks, Sheila Adamu, Benedict Apaw Agyei, Manolo Agbenorku, Nyantakyi Adu-Darko, Mercy Adomah Oteng, Vida Obese, Rexford Adu Gyamfi, Nathaniel Adusei Mensah, Raelle Tagge, Michael Ampofo, Samuel Amoabeng Kontoh, Samuel Blay Nguah, Bruce Ovbiagele
BACKGROUND: A cardiovascular polypill containing generic drugs might facilitate sustained implementation of and adherence to evidence-based treatments, especially in resource-limited settings. However, the impact of a cardiovascular polypill in mitigating atherosclerotic risk among stroke survivors has not been assessed. We aimed to compare a polypill regimen with usual care on carotid intima-media thickness (CIMT) regression after ischaemic stroke. METHODS: In SMAART, a phase 2 parallel, open-label, assessor-masked, randomised clinical trial, we randomly allocated individuals (aged ≥18 years) who had an ischaemic stroke within the previous 2 months, using a computer-generated randomisation sequence (1:1), to either a polypill or usual care group at a tertiary centre in Ghana...
October 2023: Lancet Global Health
https://read.qxmd.com/read/37690632/associations-of-baseline-and-longitudinal-serum-uromodulin-with-kidney-failure-and-mortality-results-from-the-african-american-study-of-kidney-disease-and-hypertension-aask-trial
#32
JOURNAL ARTICLE
Teresa K Chen, Michelle M Estrella, Lawrence J Appel, Aditya L Surapaneni, Anna Köttgen, Wassim Obeid, Chirag R Parikh, Morgan E Grams
RATIONALE & OBJECTIVE: Uromodulin (UMOD) is the most abundant protein found in urine and has emerged as a promising biomarker of tubule health. Circulating UMOD is also detectable, but at lower levels. We evaluated whether serum UMOD levels were associated with the risks of incident kidney failure with replacement therapy (KFRT) and mortality. STUDY DESIGN: Prospective cohort. SETTING & PARTICIPANTS: Participants in AASK (the African American Study of Kidney Disease and Hypertension) with available stored serum samples from the 0-, 12-, and 24-month visits for biomarker measurement...
January 2024: American Journal of Kidney Diseases
https://read.qxmd.com/read/37648584/renin-angiotensin-aldosterone-system-inhibitors-and-mortality-risk-in-elderly-patients-with-atrial-fibrillation-insights-from-the-nationwide-start-registry
#33
JOURNAL ARTICLE
Danilo Menichelli, Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Pasquale Pignatelli, Daniele Pastori
BACKGROUND: Arterial hypertension is the most common cardiovascular comorbidity in atrial fibrillation (AF). Few studies investigated management strategies of hypertension in AF. MATERIALS AND METHODS: We included 5769 AF patients on oral anticoagulants from the nationwide ongoing Italian START registry. We investigated the prescription of antihypertensive drugs and mortality risk. Subgroup analyses according to sex and major cardiovascular comorbidities were performed...
August 28, 2023: European Journal of Internal Medicine
https://read.qxmd.com/read/37626567/the-impact-of-some-modulators-of-the-renin-angiotensin-system-on-the-scopolamine-induced-memory-loss-mice-model
#34
JOURNAL ARTICLE
Daniela-Carmen Ababei, Ioana-Miruna Balmus, Walther Bild, Alin Stelian Ciobica, Radu Marian Lefter, Răzvan-Nicolae Rusu, Gabriela Dumitrita Stanciu, Sabina Cojocaru, Monica Hancianu, Veronica Bild
As some of the renin-angiotensin-aldosterone system (RAAS)-dependent mechanisms underlying the cognitive performance modulation could include oxidative balance alterations, in this study we aimed to describe some of the potential interactions between RAAS modulators (Losartan and Ramipril) and oxidative stress in a typical model of memory impairment. In this study, 48 white male Swiss mice were divided into six groups and received RAAS modulators (oral administration Ramipril 4 mg/kg, Losartan 20 mg/kg) and a muscarinic receptors inhibitor (intraperitoneal injection scopolamine, 0...
August 16, 2023: Brain Sciences
https://read.qxmd.com/read/37615850/ramipril-for-the-treatment-of-covid-19-ramic-a-randomized-double-blind-placebo-controlled-clinical-trial
#35
JOURNAL ARTICLE
Daniel Q Huang, Veeral Ajmera, Christian Tomaszewski, Andrew LaFree, Ricki Bettencourt, Wesley K Thompson, Davey M Smith, Atul Malhotra, Ravindra L Mehta, Vaishal Tolia, Jeffrey Yin, Paul A Insel, Stone Leachman, Jinho Jung, Summer Collier, Lisa Richards, Kristin Woods, Maral Amangurbanova, Archana Bhatt, Xinlian Zhang, Oana M Penciu, Stuart Zarich, Tamrat Retta, Michelle S Harkins, J Pedro Teixeira, Brian Chinnock, Netanya S Utay, Jordan E Lake, Rohit Loomba
INTRODUCTION: Retrospective studies report that angiotensin-converting enzyme inhibitors (ACEIs) may reduce the severity of COVID-19, but prospective data on de novo treatment with ACEIs are limited. The RAMIC trial was a randomized, multicenter, placebo-controlled, double-blind, allocation-concealed clinical trial to examine the efficacy of de novo ramipril versus placebo for the treatment of COVID-19. METHODS: Eligible participants were aged 18 years and older with a confirmed diagnosis of SARS-CoV-2 infection, recruited from urgent care clinics, emergency departments, and hospital inpatient wards at eight sites in the USA...
August 24, 2023: Advances in Therapy
https://read.qxmd.com/read/37609931/sex-differences-in-clinical-characteristics-and-outcomes-after-myocardial-infarction-with-low-ejection-fraction-insights-from-paradise-mi
#36
JOURNAL ARTICLE
Xiaowen Wang, Karola S Jering, Maja Cikes, Mariya P Tokmakova, Roxana Mehran, Yaling Han, Cara East, Freny Vaghaiwalla Mody, Yi Wang, Eldrin F Lewis, Brian Claggett, John J V McMurray, Christopher B Granger, Marc A Pfeffer, Scott D Solomon
Background Studies demonstrated sex differences in outcomes following acute myocardial infarction, with women more likely to develop heart failure (HF). Sacubitril/valsartan has been shown to reduce cardiovascular death and HF hospitalizations in patients with HF with reduced ejection fraction. Methods and Results A total of 5661 patients (1363 women [24%]) with acute myocardial infarction complicated by reduced left ventricular ejection fraction (≤40%), pulmonary congestion, or both and ≥1 of 8 risk-augmenting factors were randomized to receive sacubitril/valsartan or ramipril...
August 23, 2023: Journal of the American Heart Association
https://read.qxmd.com/read/37608699/impact-of-concomitant-cardiovascular-medications-on-overall-survival-in-patients-with-liver-cirrhosis
#37
JOURNAL ARTICLE
Moying Li, Timo Itzel, Nathally Espinosa Montagut, Thomas Falconer, Jimmy Daza, Jimyung Park, Jae Youn Cheong, Rae Woong Park, Isabella Wiest, Matthias Philip Ebert, George Hripcsak, Andreas Teufel
OBJECTIVES OF THE ARTICLE: Liver cirrhosis is the end-stage liver disease associated with poor prognosis and cardiovascular comorbidity could significantly impact mortality of cirrhotic patients. We conducted a large, retrospective study to investigate the survival impact of cardiovascular co-medications in patients with liver cirrhosis. MATERIALS AND METHODS: A study-specific R package was processed on the local databases of partner institutions within the Observational Health Data Sciences and Informatics consortium, namely Columbia University, New York City (NYC), USA and Ajou University School of Medicine (AUSOM), South Korea...
August 22, 2023: Scandinavian Journal of Gastroenterology
https://read.qxmd.com/read/37595176/formulation-and-in-vitro-evaluation-of-a-ramipril-entrapped-in-a-microsponge-based-drug-delivery-system
#38
JOURNAL ARTICLE
Hassanien Sagban Taghi, Mustafa R Abdulbaqi, Laith Hamza Samein, Maha H Philip Rahmani
Microsponges are porous cross-linked polymers, which have the ability to load a wide range of pharmaceutical active ingredients. They are used topically for long-term treatment applications in addition to the oral route of administration. They are characterized by the efficient distribution of active ingredients, which are loaded at a low quantity to release the drug over longer periods of time by altering the release characteristics. The objective of this study was to develop a novel drug-delivery system that included ramipril microsponges...
2023: International Journal of Pharmaceutical Compounding
https://read.qxmd.com/read/37572991/effect-of-pharmacological-heart-failure-drugs-and-gene-therapy-on-danon-s-cardiomyopathy
#39
JOURNAL ARTICLE
Dor Yadin, Tali Guetta, Zachary Petrover, Ronny Alcalai, Jon Seidman, Christine E Seidman, Efrat Ofek, Ran Kornowski, Edith Hochhauser, Michael Arad
Danon disease is an X-linked genetic disease resulting from LAMP2 mutations leading to defective lysosomal function. Heart failure is the main causes of morbidity and mortality. Mice with an LAMP2-exon-6-deletion (L2Δ6 ), develop cardiac hypertrophy followed by dilated cardiomyopathy, in association with accumulation of autophagosomes, fibrosis and oxidative stress. We investigated the effect of drugs used to treat heart failure and of LAMP2 gene therapy on the phenotype, molecular markers and ROS in LAMP2 cardiomyopathy...
August 10, 2023: Biochemical Pharmacology
https://read.qxmd.com/read/37543980/appraisal-of-anti-inflammatory-and-immunomodulatory-potential-of-ramipril-against-freund-s-adjuvant-provoked-arthritic-rat-model
#40
JOURNAL ARTICLE
Sumera Qasim, Yusra Habib Khan, Ambreen Malik Uttra, Nasser Hadal Alotaibi, Abdullah Salah Alanazi, Abdulaziz I Alzarea, Ahmed D Alatawi, Tauqeer Hussain Mallhi
Because of evident role of renin-angiotensin system in the etiology of rheumatoid arthritis, the current study's objective was to assess the anti-arthritic efficacy of ramipril through CFA-instigated arthritic model. The drug has been shown to have anti-inflammatory potential. CFA-instigated arthritic model assessed the anti-arthritic efficacy of ramipril by estimating different parameters, including paw volume, arthritic index scoring, haematological and biochemical attributes, histological and radiographic analyses, and various cytokines level...
August 6, 2023: Inflammopharmacology
keyword
keyword
55573
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.